{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:50:33Z","timestamp":1790383833836,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s40261-025-01486-z","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T12:54:30Z","timestamp":1759928070000},"page":"997-1005","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Budget Impact and Financial Analysis of Outpatient Dalbavancin in an Urban, Non-Teaching, Community Hospital"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0173-3313","authenticated-orcid":false,"given":"Karan","family":"Raja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onrina","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitesh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Philips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"issue":"6","key":"1486_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae267","volume":"11","author":"V Vella","year":"2024","unstructured":"Vella V, Derreumaux D, Aris E, et al. The incidence of skin and soft tissue infections in the United States and associated healthcare utilization between 2010 and 2020. Open Forum Infect Dis. 2024;11(6):ofae267. https:\/\/doi.org\/10.1093\/ofid\/ofae267.","journal-title":"Open Forum Infect Dis"},{"issue":"8","key":"1486_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa293","volume":"7","author":"AA Vazquez Deida","year":"2020","unstructured":"Vazquez Deida AA, Shihadeh KC, Preslaski CR, Young HL, Wyles DL, Jenkins TC. Use of a standardized dalbavancin approach to facilitate earlier hospital discharge for vulnerable patients receiving prolonged inpatient antibiotic therapy. Open Forum Infect Dis. 2020;7(8):ofaa293.","journal-title":"Open Forum Infect Dis"},{"key":"1486_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmacy10010001","volume":"10","author":"K Antosz","year":"2022","unstructured":"Antosz K, Al-Hasan MN, Lu ZK, et al. Clinical utility and cost effectiveness of long-acting lipoglycopeptides used in deep-seated infections among patients with social and economic barriers to care. Pharmacy. 2022;10:1.","journal-title":"Pharmacy"},{"issue":"2","key":"1486_CR4","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1155\/2008\/846453","volume":"19","author":"V Ki","year":"2008","unstructured":"Ki V, Rotstein C. Bacterial skin and soft tissue infections in adults: a review of their epidemiology, pathogenesis, diagnosis, treatment, and site of care. Can J Infect Dis Med Microbiol. 2008;19(2):173\u201384.","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"2","key":"1486_CR5","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab589","volume":"9","author":"AR Cain","year":"2022","unstructured":"Cain AR, Bremmer DN, Carr DR, et al. Effectiveness of dalbavancin compared with standard of care for the treatment of osteomyelitis: a real-world analysis. Open Forum Infect Dis. 2022;9(2):ofab589.","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"1486_CR6","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1056\/NEJMoa1710926","volume":"380","author":"HK Li","year":"2019","unstructured":"Li HK, Rombach I, Zambellas R, et al. Oral versus intravenous antibiotics for bone and joint infection. N Engl J Med. 2019;380(5):425\u201336.","journal-title":"N Engl J Med"},{"issue":"1","key":"1486_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy331","volume":"6","author":"U Rappo","year":"2019","unstructured":"Rappo U, Puttagunta S, Shevchenko V, et al. Dalbavancin for the treatment of osteomyelitis in adult patients: a randomized clinical trial of efficacy and safety. Open Forum Infect Dis. 2019;6(1):ofy331.","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"1486_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s40121-019-0247-0","volume":"8","author":"JT Bork","year":"2019","unstructured":"Bork JT, Heil EL, Berry S, et al. Dalbavancin use in vulnerable patients receiving outpatient parenteral antibiotic therapy for invasive Gram-positive infections. Infect Dis Ther. 2019;8(2):171\u201384.","journal-title":"Infect Dis Ther"},{"issue":"4","key":"1486_CR9","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1128\/AAC.04550-14","volume":"59","author":"MW Dunne","year":"2015","unstructured":"Dunne MW, Puttagunta S, Sprenger CR, Rubino C, Van Wart S, Baldassarre J. Extended-duration dosing and distribution of dalbavancin into bone and articular tissue. Antimicrob Agents Chemother. 2015;59(4):1849\u201355.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"1486_CR10","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1186\/s12913-018-3751-0","volume":"18","author":"SS Almarzoky Abuhussain","year":"2018","unstructured":"Almarzoky Abuhussain SS, Burak MA, Kohman KN, et al. Patient preferences for treatment of acute bacterial skin and skin structure infections in the emergency department. BMC Health Serv Res. 2018;18(1):932.","journal-title":"BMC Health Serv Res"},{"issue":"7","key":"1486_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz274","volume":"6","author":"T Morrisette","year":"2019","unstructured":"Morrisette T, Miller MA, Montague BT, Barber GR, McQueen RB, Krsak M. Long-acting lipoglycopeptides: \u201clineless antibiotics\u201d for serious infections in persons who use drugs. Open Forum Infect Dis. 2019;6(7):ofz274.","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"1486_CR12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1093\/cid\/ciu296","volume":"59","author":"DL Stevens","year":"2014","unstructured":"Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59(2):10\u201352.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"1486_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz217","volume":"6","author":"C Ihm","year":"2019","unstructured":"Ihm C, Sutton JD, Timbrook TT, Spivak ES. Treatment duration and associated outcomes for skin and soft tissue infections in patients with obesity or heart failure. Open Forum Infect Dis. 2019;6(6):ofz217.","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"1486_CR14","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/phar.2118","volume":"38","author":"AM Hanretty","year":"2018","unstructured":"Hanretty AM, Gallagher JC. Shortened courses of antibiotics for bacterial infections: a systematic review of randomized controlled trials. Pharmacotherapy. 2018;38(6):674\u201387.","journal-title":"Pharmacotherapy"},{"issue":"6","key":"1486_CR15","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1093\/cid\/civ482","volume":"61","author":"EF Berbari","year":"2015","unstructured":"Berbari EF, Kanj SS, Kowalski TJ, et al. 2015 Infectious Diseases Society of America (IDSA) clinical practice guidelines for the diagnosis and treatment of native vertebral osteomyelitis in adults. Clin Infect Dis. 2015;61(6):e26-46.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"1486_CR16","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1093\/cid\/cis346","volume":"54","author":"BA Lipsky","year":"2012","unstructured":"Lipsky BA, Berendt AR, Cornia PB, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012;54(12):132\u201373.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1486_CR17","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1093\/cid\/ciq146","volume":"52","author":"C Liu","year":"2011","unstructured":"Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52(3):e18\u201355.","journal-title":"Clin Infect Dis"},{"key":"1486_CR18","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1001\/archinte.164.15.1669","volume":"164","author":"MJ Hepburn","year":"2004","unstructured":"Hepburn MJ, Dooley DP, Skidmore PJ, Ellis MW, Starnes WF, Hasewinkle WC. Comparison of short course (5 days) and standard (10 days) treatment for uncomplicated cellulitis. Arch Intern Med. 2004;164:1669\u201374.","journal-title":"Arch Intern Med"},{"issue":"1","key":"1486_CR19","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/cis803","volume":"56","author":"DR Osmon","year":"2013","unstructured":"Osmon DR, Berbari EF, Berendt AR, et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013;56(1):e1\u201325.","journal-title":"Clin Infect Dis"},{"key":"1486_CR20","first-page":"447","volume":"5","author":"JM Stephens","year":"2013","unstructured":"Stephens JM, Gao X, Patel DA, Verheggen BG, Shelbaya A, Haider S. Economic burden of inpatient and outpatient antibiotic treatment for methicillin-resistant Staphylococcus aureus complicated skin and soft-tissue infections: a comparison of linezolid, vancomycin, and daptomycin. Clinocoecon Outcomes Res. 2013;5:447\u201357.","journal-title":"Clinocoecon Outcomes Res"},{"issue":"1","key":"1486_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1136\/ejhpharm-2020-002315","volume":"29","author":"M Arrieta-Loitegui","year":"2022","unstructured":"Arrieta-Loitegui M, Caro-Teller JM, Ortiz-P\u00e9rez S, L\u00f3pez-Medrano F, San Juan-Garrido R, Ferrari-Piquero JM. Effectiveness, safety and cost analysis of dalbavancin in clinical practice. Eur J Hosp Pharm. 2022;29(1):55\u20138.","journal-title":"Eur J Hosp Pharm"},{"issue":"5","key":"1486_CR22","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.ijantimicag.2019.08.007","volume":"54","author":"AC Streifel","year":"2019","unstructured":"Streifel AC, Sikka MK, Bowen CD, Lewis JS. Dalbavancin use in an academic medical centre and associated cost savings. Int J Antimicrob Agents. 2019;54(5):652\u20134.","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"1486_CR23","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s40121-020-00347-w","volume":"9","author":"AG Pizzuti","year":"2020","unstructured":"Pizzuti AG, Murray EY, Wagner JL, Gaul DA, Bland CM, Jones BM. Financial analysis of dalbavancin for acute bacterial skin and skin structure infections for self-pay patients. Infect Dis Ther. 2020;9(4):1043\u201353.","journal-title":"Infect Dis Ther"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-025-01486-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40261-025-01486-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-025-01486-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T13:05:34Z","timestamp":1764594334000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40261-025-01486-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1486"],"URL":"https:\/\/doi.org\/10.1007\/s40261-025-01486-z","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]},"assertion":[{"value":"7 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All authors contributed to the study conception and design (KR, BC, OC, MP, and MP). KR, BC, and MP performed material preparation, data collection and analysis. OC completed statistical analyses. KR and BC wrote the first draft of the manuscript and all authors critically appraised previous versions of the manuscript (KR, BC, OC, MP, and MP). All authors read and approved the final manuscript and agree to be accountable for the work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"The Cooperman Barnabas Medical Center Institutional Review Board and the Clara Maass Medical Center Institutional Review Committee approved this retrospective study [study ID 20-10cmmc].","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The Cooperman Barnabas Medical Center Institutional Review Board and the Clara Maass Medical Center Institutional Review Committees approved a waiver of informed consent due to nature of study design.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Available upon reasonable request\u00a0to K. Raja.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}